Clariant increased sales, profitability and operating cash

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
40
Clariant increased sales, profitability and operating cash flow in 2018
Sales increased by 5 % in local currency to CHF 6.623 billion EBITDA before exceptional items improved by 5 % in Swiss francs, exceeding CHF 1 billion EBITDA margin before exceptional items expanded to 15.4 % Net income climbed by 18 % to CHF 356 million Operating cash flow rose by 24 % to CHF 530 million Proposed dividend increase of 10 % to CHF 0.55 per share Outlook 2021: above-market growth, higher profitability and stronger cash generation    
 

"In 2018, Clariant achieved good sales and profit growth and significantly improved operating cash flow despite an increasingly challenging environment." said Ernesto Occhiello, CEO of Clariant. "Going forward, we will continue to identify and address the next challenges and future demands within our respective businesses and those of our customers. This, coupled with best customer experience and fast, reliable customer fulfillment will trigger above-market growth, higher profitability and stronger cash generation."

Key Financial Data

  Fourth Quarter Full Year
in CHF million 2018 2017 % CHF % LC 2018 2017 % CHF % LC
Sales 1 629 1 679 -3 3 6 623 6 377 4 5
EBITDA before exceptional items 253 257 -2   1 018 974 5  
- margin 15.5 % 15.3 %     15.4 % 15.3 %    
EBITDA after exceptional items         871 813 7  
- margin         13.2 % 12.7 %    
EBIT         546 496 10  
Net income         356 302    
Operating cash flow         530 428    
Number of employees*         17 901 18 135    

* as of 31 December

Full Year 2018 - Higher sales and continued EBITDA expansion

Muttenz, February 13, 2019 - Clariant, a focused and innovative specialty chemical company, today announced full year 2018 sales of CHF 6.623 billion compared to CHF 6.377 billion in 2017. This corresponds to 5 % growth in local currency, all of which is organic, driven by a progression in all Business Areas, particularly in Catalysis. Both higher volumes and pricing underpinned this expansion.

For the full year, all regions contributed to the sales growth in local currency. Sales in Latin America grew the strongest, by 12 %. Sales in Asia increased by 7 %, bolstered by a particularly positive development in China and India. In North America, sales rose by 5 %. Both Europe and the Middle East & Africa increased sales by 2 %.

The improved sales performance for the full year resulted from growth in all Business Areas with Care Chemicals, Catalysis and Natural Resources reporting strong expansion. Sales in Care Chemicals rose by 7 % in local currency primarily supported by Consumer Care. Catalysis sales improved by an excellent 11 % in local currency with a strong organic sales growth amounting to 8 %.

Natural Resources sales accelerated by 8 % in local currency, mainly lifted by improved Oil & Mining Services demand and solid growth in Functional Minerals. In Plastics & Coatings, sales rose by 1 % in local currency with particularly strong regional expansion in Latin America.

EBITDA before exceptional items rose by 5 % in Swiss francs and reached CHF 1.018 billion, compared to CHF 974 million in the previous year. The absolute profitability improvement was attributable to the positive contributions from Care Chemicals, Catalysis and Plastics & Coatings.

The corresponding EBITDA margin before exceptional items advanced to 15.4 % from 15.3 % in the previous year.

Net income climbed by 18 % to CHF 356 million from CHF 302 million in full year 2017. This increase was supported by the improvement in absolute EBITDA as well as lower one-off costs and a lower effective tax rate.

Operating cash flow rose significantly by 24 % to CHF 530 million from CHF 428 million in the previous year due to the improved absolute EBITDA and net working capital management. This positive development is particularly noteworthy given the one-off tax settlement amounting to CHF 83 million paid in the first half of 2018.

Net debt decreased to CHF 1.374 billion versus CHF 1.539 billion recorded at the end of 2017.

The continued improvement in performance allows the Board of Directors to propose a dividend of CHF 0.55 per share to the Annual General Meeting. This sum reflects an increase of 10 % compared to the previous year. This distribution is proposed to be made from the capital contribution reserve, which is exempt from Swiss withholding tax.

Fourth Quarter 2018 - Improvement in local currency sales and profitability

In the fourth quarter of 2018, sales rose by 3 % in local currency to CHF 1.629 billion. This represents a decrease of 3 % in Swiss francs year-on-year due to unfavorable currency fluctuations. The sales growth in local currency was mainly driven by Catalysis and Natural Resources.

Almost all regions contributed to the growth. In the Middle East & Africa, sales in local currency grew by a robust 15 % driven mainly by Catalysis. Sales in Latin America increased by 9 % in local currency supported by Oil & Mining Services, in North America by a solid 3 % and in Asia by 2 % with a slowing in China. Only sales in Europe had a negative growth of 2 % largely due to the particularly challenging comparison base.

Catalysis sales grew by 9 % in local currency mainly as a result of higher demand for Petrochemical Catalysts. Natural Resources sales climbed by 11 % in local currency with positive contributions from both the Oil & Mining Services as well as the Functional Minerals businesses. Sales in Care Chemicals rose by 1 % in local currency, supported by the Consumer Care businesses. Sales in Plastics & Coatings were 3 % lower in local currency due to the softening demand in Asia and Europe in particular.

EBITDA before exceptional items decreased by 2 % in Swiss francs to CHF 253 million from CHF 257 million in the previous year, driven by the temporary softer margins in Care Chemicals and Natural Resources.

Nevertheless, the EBITDA margin before exceptional items on Group level increased to 15.5 % from 15.3 % in the previous year due to the strong margin improvement in Catalysis which more than compensated for the profitability softness in Care Chemicals and Natural Resources.

Outlook 2021 - above-market growth, higher profitability and stronger cash generation

Clariant is a focused and innovative specialty chemical company. We aim to provide more than just customer-oriented products. We strive to provide the best customer experience and fast, reliable customer fulfillment in the industry by setting the right priorities.

Our aim is to make our customers more successful. We therefore constantly focus on timely and rewarding innovations, products that are difficult to imitate, sustainability, agility as well as ethical practices. We will only be satisfied with the highest level of excellence in every function within the Group. Our success will be realized through the execution of our strategy.

We confirm our 2021 guidance to achieve above-market growth, higher profitability and stronger cash generation.

Corporate Media Relations Investor Relations
Jochen Dubiel Phone +41 61 469 63 63 jochen.dubiel@clariant.com Anja Pomrehn Phone +41 61 469 67 45 anja.pomrehn@clariant.com
Thijs Bouwens Phone +41 61 469 63 63 thijs.bouwens@clariant.com Maria Ivek Phone +41 61 469 63 73 maria.ivek@clariant.com
   
Follow us on Twitter , Facebook , Google Plus , LinkedIn .  
    This media release contains certain statements that are neither reported financial results nor other historical information. This document also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company's ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.     www.clariant.com      
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 43

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 49

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 87

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
Mining Equipment Market to Surge, Hitting $42.81B by 2033

Updated Category News Views 12

Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 34

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 55

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 53

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 54

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
KuCoin Unveils $1.1M USDT Black Friday Bonanza

Updated Category News Views 31

KuCoin's Festive Fireworks: Black Friday Bonanza Sometimes the crypto world feels like a carnival, and KuCoin's latest act is the $1.1 million USDT prize pool, rolling out as part of its 'Tis The Season holiday campaign. A move that matches the glitz of Tomorrowland Winter experiences, adding more sparkle to the crypto stage. Behind the Scenes of the KuCoin-Tomorrowland...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 41

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Challenge: Investors Pursue Justice Against TLX

Updated Category News Views 164

Opportunity for Investors in Telix Pharmaceuticals Ltd. Attention, investors! A significant event has unfolded for those who have purchased securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). The Rosen Law Firm, well-known for representing investors' rights, has initiated a class action lawsuit on behalf of these investors. This development presents a chance for you...

Continue Reading
Turvo and SMC3 Forge Alliance to Enhance Freight Efficiency

Updated Category News Views 158

Strategic Partnership Between Turvo and SMC3 Industry leaders are joining forces to enhance freight management solutions, facilitated by insights from a global logistics company. Turvo, known for its collaborative application tailored for the supply chain, has announced an integration partnership with SMC3, a respected provider of less-than-truckload (LTL) freight...

Continue Reading
Fnac Darty Takes Major Steps in Unieuro Acquisition Process

Updated Category News Views 148

Fnac Darty Makes Progress in Unieuro Acquisition Fnac Darty has recently announced significant developments regarding its acquisition of Unieuro. The authorization to officially notify this transaction was granted by the European Commission, following a pre-notification phase that lasted several months. This is an exciting development for shareholders and has set the...

Continue Reading
LOGISTEC Appoints Cleidy Liborio Fernandes as CCO for Growth

Updated Category News Views 202

CLEIDY LIBORIO FERNANDES JOINS LOGISTEC AS CHIEF COMMERCIAL OFFICER LOGISTEC, a prominent provider of marine and environmental services in North America, is delighted to announce the appointment of Cleidy Liborio Fernandes as the new Chief Commercial Officer. Cleidy's extensive background in international business and strategic development is expected to spearhead the...

Continue Reading
IMUNON Inc's Latest Developments Drive Stock Surge Today

Updated Category News Views 233

IMUNON Inc's Stock Surge Explained Shares of IMUNON Inc (NASDAQ: IMNN) are seeing a remarkable uptick in trading this Wednesday. The excitement is largely due to the company achieving a significant clinical milestone for its lead drug candidate, IMNN-001. This news has generated substantial interest among investors and highlights IMUNON's progress in the pharmaceutical...

Continue Reading